Omnimed Capital

Private Equity Exempt reporting adviser

Legal name: Omnimed Capital LLC

Dallas, TX Website

AUM

$56.1M
Private fund assets

Private funds

4
Private Equity 4

Private fund assets

$56.1M
Gross asset value

Employees

—

Last Form D raise

Aug 2026
Most recent fund filing

From SEC Form ADV filing (filed Mar 31, 2026). View on SEC

People(2)

Owners and executive officers named on the firm's SEC Form ADV.

G
Managing Director and President
G
Managing Director and Chief Investment Officer

Funds(4)

Private funds reported on Form ADV, with amounts raised from the funds' SEC Form D filings.

FundTypeGross assetsRaised (Form D)InvestorsLast Form DRecency
Omnimed Equity Partners II LPPrivate Equity$10.8M$10.6M60Aug 2026Hot
Omnimed Equity Partners IV, LPPrivate Equity$3.5M$3.6M43Feb 2026Warm
Omnimed Equity Partners, LPPrivate Equity$31.8M$14.1M78Aug 2022Cold
Omnimed Equity Partners Coinvest, LPPrivate Equity$10.0M$6.1M10Aug 2022Cold

Board seats(1)

Companies whose SEC Form D filings name one of this firm's people as a director, matched by name and office ZIP code.

Klaris
BiotechnologyAustin, TXDirector: Gregory Wood
$83.7M raised
Since Apr 2018
SEC Form D

Regulatory identifiers

CRD number
326628
SEC file number
802-128964

Sources